 | • レポートコード：MRC2-11QY04595 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は性腺性腺間質腫瘍のグローバル市場について調査・分析したレポートです。種類別（診断、治療）市場規模、用途別（病院用、診療所用、研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別性腺性腺間質腫瘍の競争状況、市場シェア ・世界の性腺性腺間質腫瘍市場：種類別市場規模 2015年-2020年（診断、治療） ・世界の性腺性腺間質腫瘍市場：種類別市場規模予測 2021年-2026年（診断、治療） ・世界の性腺性腺間質腫瘍市場：用途別市場規模 2015年-2020年（病院用、診療所用、研究センター、その他） ・世界の性腺性腺間質腫瘍市場：用途別市場規模予測 2021年-2026年（病院用、診療所用、研究センター、その他） ・北米の性腺性腺間質腫瘍市場分析：米国、カナダ ・ヨーロッパの性腺性腺間質腫瘍市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの性腺性腺間質腫瘍市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の性腺性腺間質腫瘍市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの性腺性腺間質腫瘍市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott, Abcam plc.、Affymetrix, Inc.、Agilent Technologies, Inc.、Beckman Dickinson and Company、Bio SB Inc.、BioCurex、BioModa, Inc.、Bio-Rad Laboratories, Inc.、Boston Scientific Corporation、Cell Signaling Technology, Inc.、Clarient, Inc.、CooperSurgical Inc.、Correlogic Systems, Inc.、Danaher Corporation、Epigenomics AG ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Sex cord-gonadal stromal tumors are mostly of seven types, namely, granulosa cell tumor, Sertoli cell tumor, thecoma, Leydig cell tumor, gynandroblastoma, Sex Cord Tumor with Annular Tubules (SCTAT), and Sertoli Leydig cell tumor. In humans, this type of tumor accounts for 8% of the ovarian cancers and around 5% of testicular cancers.
The Americas dominates the sex cord-gonadal stromal tumor market owing to the increasing prevalence of ovarian cancer in this region and high healthcare expenditure.
Market Analysis and Insights: Global Sex Cord Gonadal Stromal Tumor Market
The global Sex Cord Gonadal Stromal Tumor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Sex Cord Gonadal Stromal Tumor Scope and Market Size
Sex Cord Gonadal Stromal Tumor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sex Cord Gonadal Stromal Tumor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott, Abcam plc.
Affymetrix, Inc.
Agilent Technologies, Inc.
Beckman Dickinson and Company
Bio SB Inc.
BioCurex
BioModa, Inc.
Bio-Rad Laboratories, Inc.
Boston Scientific Corporation
Cell Signaling Technology, Inc.
Clarient, Inc.
CooperSurgical Inc.
Correlogic Systems, Inc.
Danaher Corporation
Epigenomics AG
Market segment by Type, the product can be split into
Diagnosis
Treatment
Market segment by Application, split into
Hospital Use
Clinic Use
Research Center
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sex Cord Gonadal Stromal Tumor Revenue
1.4 Market by Type
1.4.1 Global Sex Cord Gonadal Stromal Tumor Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnosis
1.4.3 Treatment
1.5 Market by Application
1.5.1 Global Sex Cord Gonadal Stromal Tumor Market Share by Application: 2020 VS 2026
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Research Center
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Sex Cord Gonadal Stromal Tumor Market Perspective (2015-2026)
2.2 Global Sex Cord Gonadal Stromal Tumor Growth Trends by Regions
2.2.1 Sex Cord Gonadal Stromal Tumor Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sex Cord Gonadal Stromal Tumor Historic Market Share by Regions (2015-2020)
2.2.3 Sex Cord Gonadal Stromal Tumor Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Sex Cord Gonadal Stromal Tumor Market Growth Strategy
2.3.6 Primary Interviews with Key Sex Cord Gonadal Stromal Tumor Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Sex Cord Gonadal Stromal Tumor Players by Market Size
3.1.1 Global Top Sex Cord Gonadal Stromal Tumor Players by Revenue (2015-2020)
3.1.2 Global Sex Cord Gonadal Stromal Tumor Revenue Market Share by Players (2015-2020)
3.1.3 Global Sex Cord Gonadal Stromal Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sex Cord Gonadal Stromal Tumor Market Concentration Ratio
3.2.1 Global Sex Cord Gonadal Stromal Tumor Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sex Cord Gonadal Stromal Tumor Revenue in 2019
3.3 Sex Cord Gonadal Stromal Tumor Key Players Head office and Area Served
3.4 Key Players Sex Cord Gonadal Stromal Tumor Product Solution and Service
3.5 Date of Enter into Sex Cord Gonadal Stromal Tumor Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Sex Cord Gonadal Stromal Tumor Historic Market Size by Type (2015-2020)
4.2 Global Sex Cord Gonadal Stromal Tumor Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020)
5.2 Global Sex Cord Gonadal Stromal Tumor Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Sex Cord Gonadal Stromal Tumor Market Size (2015-2020)
6.2 Sex Cord Gonadal Stromal Tumor Key Players in North America (2019-2020)
6.3 North America Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020)
6.4 North America Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020)
7 Europe
7.1 Europe Sex Cord Gonadal Stromal Tumor Market Size (2015-2020)
7.2 Sex Cord Gonadal Stromal Tumor Key Players in Europe (2019-2020)
7.3 Europe Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020)
7.4 Europe Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020)
8 China
8.1 China Sex Cord Gonadal Stromal Tumor Market Size (2015-2020)
8.2 Sex Cord Gonadal Stromal Tumor Key Players in China (2019-2020)
8.3 China Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020)
8.4 China Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020)
9 Japan
9.1 Japan Sex Cord Gonadal Stromal Tumor Market Size (2015-2020)
9.2 Sex Cord Gonadal Stromal Tumor Key Players in Japan (2019-2020)
9.3 Japan Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020)
9.4 Japan Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Sex Cord Gonadal Stromal Tumor Market Size (2015-2020)
10.2 Sex Cord Gonadal Stromal Tumor Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020)
10.4 Southeast Asia Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020)
11 India
11.1 India Sex Cord Gonadal Stromal Tumor Market Size (2015-2020)
11.2 Sex Cord Gonadal Stromal Tumor Key Players in India (2019-2020)
11.3 India Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020)
11.4 India Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Sex Cord Gonadal Stromal Tumor Market Size (2015-2020)
12.2 Sex Cord Gonadal Stromal Tumor Key Players in Central & South America (2019-2020)
12.3 Central & South America Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020)
12.4 Central & South America Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott, Abcam plc.
13.1.1 Abbott, Abcam plc. Company Details
13.1.2 Abbott, Abcam plc. Business Overview
13.1.3 Abbott, Abcam plc. Sex Cord Gonadal Stromal Tumor Introduction
13.1.4 Abbott, Abcam plc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020))
13.1.5 Abbott, Abcam plc. Recent Development
13.2 Affymetrix, Inc.
13.2.1 Affymetrix, Inc. Company Details
13.2.2 Affymetrix, Inc. Business Overview
13.2.3 Affymetrix, Inc. Sex Cord Gonadal Stromal Tumor Introduction
13.2.4 Affymetrix, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020)
13.2.5 Affymetrix, Inc. Recent Development
13.3 Agilent Technologies, Inc.
13.3.1 Agilent Technologies, Inc. Company Details
13.3.2 Agilent Technologies, Inc. Business Overview
13.3.3 Agilent Technologies, Inc. Sex Cord Gonadal Stromal Tumor Introduction
13.3.4 Agilent Technologies, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020)
13.3.5 Agilent Technologies, Inc. Recent Development
13.4 Beckman Dickinson and Company
13.4.1 Beckman Dickinson and Company Company Details
13.4.2 Beckman Dickinson and Company Business Overview
13.4.3 Beckman Dickinson and Company Sex Cord Gonadal Stromal Tumor Introduction
13.4.4 Beckman Dickinson and Company Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020)
13.4.5 Beckman Dickinson and Company Recent Development
13.5 Bio SB Inc.
13.5.1 Bio SB Inc. Company Details
13.5.2 Bio SB Inc. Business Overview
13.5.3 Bio SB Inc. Sex Cord Gonadal Stromal Tumor Introduction
13.5.4 Bio SB Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020)
13.5.5 Bio SB Inc. Recent Development
13.6 BioCurex
13.6.1 BioCurex Company Details
13.6.2 BioCurex Business Overview
13.6.3 BioCurex Sex Cord Gonadal Stromal Tumor Introduction
13.6.4 BioCurex Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020)
13.6.5 BioCurex Recent Development
13.7 BioModa, Inc.
13.7.1 BioModa, Inc. Company Details
13.7.2 BioModa, Inc. Business Overview
13.7.3 BioModa, Inc. Sex Cord Gonadal Stromal Tumor Introduction
13.7.4 BioModa, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020)
13.7.5 BioModa, Inc. Recent Development
13.8 Bio-Rad Laboratories, Inc.
13.8.1 Bio-Rad Laboratories, Inc. Company Details
13.8.2 Bio-Rad Laboratories, Inc. Business Overview
13.8.3 Bio-Rad Laboratories, Inc. Sex Cord Gonadal Stromal Tumor Introduction
13.8.4 Bio-Rad Laboratories, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020)
13.8.5 Bio-Rad Laboratories, Inc. Recent Development
13.9 Boston Scientific Corporation
13.9.1 Boston Scientific Corporation Company Details
13.9.2 Boston Scientific Corporation Business Overview
13.9.3 Boston Scientific Corporation Sex Cord Gonadal Stromal Tumor Introduction
13.9.4 Boston Scientific Corporation Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020)
13.9.5 Boston Scientific Corporation Recent Development
13.10 Cell Signaling Technology, Inc.
13.10.1 Cell Signaling Technology, Inc. Company Details
13.10.2 Cell Signaling Technology, Inc. Business Overview
13.10.3 Cell Signaling Technology, Inc. Sex Cord Gonadal Stromal Tumor Introduction
13.10.4 Cell Signaling Technology, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020)
13.10.5 Cell Signaling Technology, Inc. Recent Development
13.11 Clarient, Inc.
10.11.1 Clarient, Inc. Company Details
10.11.2 Clarient, Inc. Business Overview
10.11.3 Clarient, Inc. Sex Cord Gonadal Stromal Tumor Introduction
10.11.4 Clarient, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020)
10.11.5 Clarient, Inc. Recent Development
13.12 CooperSurgical Inc.
10.12.1 CooperSurgical Inc. Company Details
10.12.2 CooperSurgical Inc. Business Overview
10.12.3 CooperSurgical Inc. Sex Cord Gonadal Stromal Tumor Introduction
10.12.4 CooperSurgical Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020)
10.12.5 CooperSurgical Inc. Recent Development
13.13 Correlogic Systems, Inc.
10.13.1 Correlogic Systems, Inc. Company Details
10.13.2 Correlogic Systems, Inc. Business Overview
10.13.3 Correlogic Systems, Inc. Sex Cord Gonadal Stromal Tumor Introduction
10.13.4 Correlogic Systems, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020)
10.13.5 Correlogic Systems, Inc. Recent Development
13.14 Danaher Corporation
10.14.1 Danaher Corporation Company Details
10.14.2 Danaher Corporation Business Overview
10.14.3 Danaher Corporation Sex Cord Gonadal Stromal Tumor Introduction
10.14.4 Danaher Corporation Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020)
10.14.5 Danaher Corporation Recent Development
13.15 Epigenomics AG
10.15.1 Epigenomics AG Company Details
10.15.2 Epigenomics AG Business Overview
10.15.3 Epigenomics AG Sex Cord Gonadal Stromal Tumor Introduction
10.15.4 Epigenomics AG Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020)
10.15.5 Epigenomics AG Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Sex Cord Gonadal Stromal Tumor Key Market Segments
Table 2. Key Players Covered: Ranking by Sex Cord Gonadal Stromal Tumor Revenue
Table 3. Ranking of Global Top Sex Cord Gonadal Stromal Tumor Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sex Cord Gonadal Stromal Tumor Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnosis
Table 6. Key Players of Treatment
Table 7. Global Sex Cord Gonadal Stromal Tumor Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Sex Cord Gonadal Stromal Tumor Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Sex Cord Gonadal Stromal Tumor Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Sex Cord Gonadal Stromal Tumor Market Share by Regions (2015-2020)
Table 11. Global Sex Cord Gonadal Stromal Tumor Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Sex Cord Gonadal Stromal Tumor Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Sex Cord Gonadal Stromal Tumor Market Growth Strategy
Table 17. Main Points Interviewed from Key Sex Cord Gonadal Stromal Tumor Players
Table 18. Global Sex Cord Gonadal Stromal Tumor Revenue by Players (2015-2020) (Million US$)
Table 19. Global Sex Cord Gonadal Stromal Tumor Market Share by Players (2015-2020)
Table 20. Global Top Sex Cord Gonadal Stromal Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sex Cord Gonadal Stromal Tumor as of 2019)
Table 21. Global Sex Cord Gonadal Stromal Tumor by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Sex Cord Gonadal Stromal Tumor Product Solution and Service
Table 24. Date of Enter into Sex Cord Gonadal Stromal Tumor Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 27. Global Sex Cord Gonadal Stromal Tumor Market Size Share by Type (2015-2020)
Table 28. Global Sex Cord Gonadal Stromal Tumor Revenue Market Share by Type (2021-2026)
Table 29. Global Sex Cord Gonadal Stromal Tumor Market Size Share by Application (2015-2020)
Table 30. Global Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 31. Global Sex Cord Gonadal Stromal Tumor Market Size Share by Application (2021-2026)
Table 32. North America Key Players Sex Cord Gonadal Stromal Tumor Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Sex Cord Gonadal Stromal Tumor Market Share (2019-2020)
Table 34. North America Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 35. North America Sex Cord Gonadal Stromal Tumor Market Share by Type (2015-2020)
Table 36. North America Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 37. North America Sex Cord Gonadal Stromal Tumor Market Share by Application (2015-2020)
Table 38. Europe Key Players Sex Cord Gonadal Stromal Tumor Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Sex Cord Gonadal Stromal Tumor Market Share (2019-2020)
Table 40. Europe Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Sex Cord Gonadal Stromal Tumor Market Share by Type (2015-2020)
Table 42. Europe Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Sex Cord Gonadal Stromal Tumor Market Share by Application (2015-2020)
Table 44. China Key Players Sex Cord Gonadal Stromal Tumor Revenue (2019-2020) (Million US$)
Table 45. China Key Players Sex Cord Gonadal Stromal Tumor Market Share (2019-2020)
Table 46. China Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 47. China Sex Cord Gonadal Stromal Tumor Market Share by Type (2015-2020)
Table 48. China Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 49. China Sex Cord Gonadal Stromal Tumor Market Share by Application (2015-2020)
Table 50. Japan Key Players Sex Cord Gonadal Stromal Tumor Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Sex Cord Gonadal Stromal Tumor Market Share (2019-2020)
Table 52. Japan Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Sex Cord Gonadal Stromal Tumor Market Share by Type (2015-2020)
Table 54. Japan Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Sex Cord Gonadal Stromal Tumor Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Sex Cord Gonadal Stromal Tumor Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Sex Cord Gonadal Stromal Tumor Market Share (2019-2020)
Table 58. Southeast Asia Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Sex Cord Gonadal Stromal Tumor Market Share by Type (2015-2020)
Table 60. Southeast Asia Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Sex Cord Gonadal Stromal Tumor Market Share by Application (2015-2020)
Table 62. India Key Players Sex Cord Gonadal Stromal Tumor Revenue (2019-2020) (Million US$)
Table 63. India Key Players Sex Cord Gonadal Stromal Tumor Market Share (2019-2020)
Table 64. India Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 65. India Sex Cord Gonadal Stromal Tumor Market Share by Type (2015-2020)
Table 66. India Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 67. India Sex Cord Gonadal Stromal Tumor Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Sex Cord Gonadal Stromal Tumor Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Sex Cord Gonadal Stromal Tumor Market Share (2019-2020)
Table 70. Central & South America Sex Cord Gonadal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Sex Cord Gonadal Stromal Tumor Market Share by Type (2015-2020)
Table 72. Central & South America Sex Cord Gonadal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Sex Cord Gonadal Stromal Tumor Market Share by Application (2015-2020)
Table 74. Abbott, Abcam plc. Company Details
Table 75. Abbott, Abcam plc. Business Overview
Table 76. Abbott, Abcam plc. Product
Table 77. Abbott, Abcam plc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 78. Abbott, Abcam plc. Recent Development
Table 79. Affymetrix, Inc. Company Details
Table 80. Affymetrix, Inc. Business Overview
Table 81. Affymetrix, Inc. Product
Table 82. Affymetrix, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 83. Affymetrix, Inc. Recent Development
Table 84. Agilent Technologies, Inc. Company Details
Table 85. Agilent Technologies, Inc. Business Overview
Table 86. Agilent Technologies, Inc. Product
Table 87. Agilent Technologies, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 88. Agilent Technologies, Inc. Recent Development
Table 89. Beckman Dickinson and Company Company Details
Table 90. Beckman Dickinson and Company Business Overview
Table 91. Beckman Dickinson and Company Product
Table 92. Beckman Dickinson and Company Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 93. Beckman Dickinson and Company Recent Development
Table 94. Bio SB Inc. Company Details
Table 95. Bio SB Inc. Business Overview
Table 96. Bio SB Inc. Product
Table 97. Bio SB Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 98. Bio SB Inc. Recent Development
Table 99. BioCurex Company Details
Table 100. BioCurex Business Overview
Table 101. BioCurex Product
Table 102. BioCurex Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 103. BioCurex Recent Development
Table 104. BioModa, Inc. Company Details
Table 105. BioModa, Inc. Business Overview
Table 106. BioModa, Inc. Product
Table 107. BioModa, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 108. BioModa, Inc. Recent Development
Table 109. Bio-Rad Laboratories, Inc. Business Overview
Table 110. Bio-Rad Laboratories, Inc. Product
Table 111. Bio-Rad Laboratories, Inc. Company Details
Table 112. Bio-Rad Laboratories, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 113. Bio-Rad Laboratories, Inc. Recent Development
Table 114. Boston Scientific Corporation Company Details
Table 115. Boston Scientific Corporation Business Overview
Table 116. Boston Scientific Corporation Product
Table 117. Boston Scientific Corporation Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 118. Boston Scientific Corporation Recent Development
Table 119. Cell Signaling Technology, Inc. Company Details
Table 120. Cell Signaling Technology, Inc. Business Overview
Table 121. Cell Signaling Technology, Inc. Product
Table 122. Cell Signaling Technology, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 123. Cell Signaling Technology, Inc. Recent Development
Table 124. Clarient, Inc. Company Details
Table 125. Clarient, Inc. Business Overview
Table 126. Clarient, Inc. Product
Table 127. Clarient, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 128. Clarient, Inc. Recent Development
Table 129. CooperSurgical Inc. Company Details
Table 130. CooperSurgical Inc. Business Overview
Table 131. CooperSurgical Inc. Product
Table 132. CooperSurgical Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 133. CooperSurgical Inc. Recent Development
Table 134. Correlogic Systems, Inc. Company Details
Table 135. Correlogic Systems, Inc. Business Overview
Table 136. Correlogic Systems, Inc. Product
Table 137. Correlogic Systems, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 138. Correlogic Systems, Inc. Recent Development
Table 139. Danaher Corporation Company Details
Table 140. Danaher Corporation Business Overview
Table 141. Danaher Corporation Product
Table 142. Danaher Corporation Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 143. Danaher Corporation Recent Development
Table 144. Epigenomics AG Company Details
Table 145. Epigenomics AG Business Overview
Table 146. Epigenomics AG Product
Table 147. Epigenomics AG Revenue in Sex Cord Gonadal Stromal Tumor Business (2015-2020) (Million US$)
Table 148. Epigenomics AG Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sex Cord Gonadal Stromal Tumor Market Share by Type: 2020 VS 2026
Figure 2. Diagnosis Features
Figure 3. Treatment Features
Figure 4. Global Sex Cord Gonadal Stromal Tumor Market Share by Application: 2020 VS 2026
Figure 5. Hospital Use Case Studies
Figure 6. Clinic Use Case Studies
Figure 7. Research Center Case Studies
Figure 8. Other Case Studies
Figure 9. Sex Cord Gonadal Stromal Tumor Report Years Considered
Figure 10. Global Sex Cord Gonadal Stromal Tumor Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Sex Cord Gonadal Stromal Tumor Market Share by Regions: 2020 VS 2026
Figure 12. Global Sex Cord Gonadal Stromal Tumor Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Sex Cord Gonadal Stromal Tumor Market Share by Players in 2019
Figure 15. Global Top Sex Cord Gonadal Stromal Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sex Cord Gonadal Stromal Tumor as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Sex Cord Gonadal Stromal Tumor Revenue in 2019
Figure 17. North America Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
性腺性腺間質腫瘍治療の世界市場（～2026年） The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Market Analysis and Insights: Global Sex Cord Gonadal Stromal Tumor Treatment Market The global Sex Cord Gonadal Strom…- 消化管間質腫瘍（GIST）の世界市場（～2026年） Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract. Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as path…
- 消化管間質腫瘍（GIST）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Gastrointestinal Stromal Tumor (GIST) Drug Market The global Gastrointestinal Stromal Tumor (GIST) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gastrointestinal Stromal Tumo…
- 消化管間質腫瘍（GIST）治療の世界市場（～2026年） A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine. Market Analysis and Insights: Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market The global Gastrointestinal Stromal Tumors (GISTs) …
- 間質血管画分の世界市場（～2026年） Stromal vascular fraction skin treatment is a type of stem cell therapy based on isolation of adipose tissue during liposuction or lipo-aspiration procedures of patient’s own body. With increasing age, regenerative and repair properties of skin are less effective due to decrease in stem cell count, …